Article

Tuzun E, Zhou L, Baehring JM, et al. Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma

Division of Neuro-Oncology, Department of Neurology, Hospital of the University of Pennsylvania, University of Pennsylvania, 3 W. Gates, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Acta Neuropathologica (Impact Factor: 10.76). 09/2009; 118(6):737-43. DOI: 10.1007/s00401-009-0582-4
Source: PubMed

ABSTRACT We report the immunopathological analysis of the brain and tumor of two patients who died of anti-NMDAR-associated encephalitis, and of the tumor of nine patients who recovered. Findings included prominent microgliosis and deposits of IgG with rare inflammatory infiltrates in the hippocampus, forebrain, basal ganglia, and spinal cord. Detection of cells expressing markers of cytotoxicity (TIA, granzyme B, perforin and Fas/Fas ligand) was extremely uncommon. All tumors showed NMDAR-expressing neurons and inflammatory infiltrates. All patients’ NMDAR antibodies were IgG1, IgG2, or IgG3. No complement deposits were observed in any of the central nervous system regions examined. Overall, these findings coupled with recently reported in vitro data showing that antibodies downregulate the levels of NMDA receptors suggest that the antibody immune-response is more relevant than cytotoxic T-cell mechanisms in the pathogenesis of anti-NMDAR-associated encephalitis.

Download full-text

Full-text

Available from: Erdem Tüzün, Jul 11, 2014
1 Follower
 · 
114 Views
  • Source
    • "However, proportionally, the infrequent immature teratomas have a much higher representation in this condition than the mature cystic ones when compared with their relative overall incidence; mature cystic teratomas are the most frequent ovarian tumors in young females. The higher ratio of immature teratomas associated with this entity can be explained by the large mass of neural tissues present in them which often differentiate neurons and their precursors [13] and that are likely to be related to the formation of Anti NMDAR antibodies [5] [10]. In mature cystic teratomas, neurons are present in only about 7–9% of tumors [14] which often have organoid arrangements reminiscent of central ganglia, cortex and cerebellum [15]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A 20-year-old female with a diagnosis of autoimmune encephalitis against N-methyl-D-aspartate receptor was found to have a 13 mm teratoma in the left ovary. The tumor had undergone massive coagulative necrosis within a normal ovary, a previously unreported feature. Necrosis of a mature cystic teratoma is very rare in the absence of ovarian torsion. It is proposed that necrosis may have induced a massive liberation of neuronal antigens. The vast majority of the tumors associated with this newly described condition are ovarian teratomas containing neural tissues. In this paper, we review their different histopathological aspects that may explain the relative incidence of various tumor types associated to this form of encephalitis. Anti N-methyl-D-aspartate receptor encephalitis has now become the most frequent autoimmune disorder associated with ovarian teratoma.
    Pathology - Research and Practice 07/2012; 208(8):497-500. DOI:10.1016/j.prp.2012.05.018 · 1.56 Impact Factor
  • Source
    • "Alternatively, our data showing that the antibodies can activate deposition of both C3b and C5b9 (membrane attack complex) on NMDAR expressing cells would be consistent with direct damage and/or complement-dependent chemotaxis being responsible for a subsequent CSF lymphocytosis. Complement deposition was not found at 3 and 4 months, respectively, in two post-mortem studies (Tuzun et al., 2009) but might be important in the early stages. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Antibodies to the N-methyl-d-aspartate subtype of glutamate receptor have been associated with a newly-described encephalopathy that has been mainly identified in young females with ovarian tumours. However, the full clinical spectrum and treatment responses are not yet clear. We established a sensitive cell-based assay for detection of N-methyl-d-aspartate receptor antibodies in serum or cerebrospinal fluid, and a quantitative fluorescent immunoprecipitation assay for serial studies. Although there was marked intrathecal synthesis of N-methyl-d-aspartate receptor antibodies, the absolute levels of N-methyl-d-aspartate receptor antibodies were higher in serum than in cerebrospinal fluid. N-methyl-d-aspartate receptor antibodies were of the immunoglobulin G1 subclass and were able to activate complement on N-methyl d-aspartate receptor-expressing human embryonic kidney cells. From questionnaires returned on 44 N-methyl-d-aspartate receptor antibody-positive patients, we identified a high proportion without a detected tumour (35/44, 80%: follow-up 3.6-121 months, median 16 months). Among the latter were 15 adult females (43%), 10 adult males (29%) and 10 children (29%), with four in the first decade of life. Overall, there was a high proportion (29%) of non-Caucasians. Good clinical outcomes, as defined by reductions in modified Rankin scores, correlated with decreased N-methyl-d-aspartate receptor antibody levels and were associated with early (<40 days) administration of immunotherapies in non-paraneoplastic patients (P < 0.0001) and earlier tumour removal in paraneoplastic patients (P = 0.02). Ten patients (23%) who were first diagnosed during relapses had no evidence of tumours but had received minimal or no immunotherapy during earlier episodes. Temporal analysis of the onset of the neurological features suggested progression through two main stages. The time of onset of the early features, characterized by neuropsychiatric symptoms and seizures preceded by a median of 10-20 days, the onset of movement disorders, reduction in consciousness and dysautonomia. This temporal dichotomy was also seen in the timing of cerebrospinal fluid, electroencephalographic and in the rather infrequent cerebral imaging changes. Overall, our data support a model in which the early features are associated with cerebrospinal fluid lymphocytosis, and the later features with appearance of oligoclonal bands. The immunological events and neuronal mechanisms underlying these observations need to be explored further, but one possibility is that the early stage represents diffusion of serum antibodies into the cortical grey matter, whereas the later stage results from secondary expansion of the immunological repertoire within the intrathecal compartment acting on subcortical neurons. Four patients, who only had temporal lobe epilepsy without oligoclonal bands, may represent restriction to the first stage.
    Brain 06/2010; 133(Pt 6):1655-67. DOI:10.1093/brain/awq113 · 10.23 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Les encéphalites auto-immunes/paranéoplasiques présentent des caractéristiques communes avec des tableaux cliniques d’évolution rapide associant des troubles du comportement ou de l’humeur, des crises convulsives, des troubles de la mémoire, une réaction inflammatoire du liquide céphalorachidien (LCR) et des modifications de l’imagerie cérébrale. Elles sont secondaires à la présence d’un anticorps dirigé le plus souvent contre des antigènes du système nerveux central (SNC), qui peuvent être communs aux antigènes exprimés par un tissu tumoral. Parmi celles-ci, les encéphalites à anticorps antirécepteurs-NMDA (anti-R-NMDA), de description récente, semblent particulièrement fréquentes. En effet, selon une étude prospective épidémiologique, ces encéphalites représenteraient 4 % de l’ensemble des causes d’encéphalites, soit la cinquième cause d’encéphalite après les infections à Herpes simplex virus, à Varicelle zona virus (VZV), à Mycobacterium tuberculosis et l’encéphalomyélite aiguë disséminée (ou acute demyelinating encephalomyelitis, ADEM), et la deuxième étiologie d’encéphalite auto-immune après l’ADEM. Les encéphalites à anticorps anti-R-NMDA touchent préférentiellement des sujets jeunes de sexe féminin et possèdent une présentation clinique évocatrice avec le développement rapide de troubles du comportement, une présentation neuropsychiatrique particulière avec des hallucinations, des crises convulsives, des mouvements anormaux, une dysautonomie et une hypoventilation centrale nécessitant fréquemment une hospitalisation en réanimation. Ce tableau est associé à un tératome ovarien dans deux tiers des cas. Le diagnostic est confirmé de façon simple par le dosage des anticorps dans le LCR, avec des arguments indirects en IRM et à l’électroencéphalogramme (EEG). La prise en charge thérapeutique repose sur une immunothérapie, une corticothérapie associée à des immunoglobulines IV (IgIV) ou des plasmaphérèses ainsi que sur la résection chirurgicale d’une tumeur germinale éventuelle. Diagnostiquée et prise en charge précocement, l’encéphalite à anticorps anti-R-NMDA a une mortalité faible, environ 4 %, et un pronostic neurologique favorable au bout de quelques mois chez plus de 75 % des patients. Paraneoplastic autoimmune encephalitis results in rapidly evolving symptoms encompassing behavior changes, mood disorders, seizures, memory deficits, and possible decline of consciousness associated to an inflammation of the cerebrospinal fluid (CSF) and abnormalities on cerebral imaging. Among these encephalitis, the recently described anti-NMDA-receptor encephalitis seems more common. According to an epidemiological prospective study, this encephalitis represents up to 4% of all causes of encephalitis; the 5th cause of encephalitis after Herpes simplex virus, Varicelle zona virus (VZV), Mycobacterium tuberculosis infections, and acute demyelinating encephalomyelitis (ADEM), and thus the second cause of autoimmune encephalitis after ADEM. Anti-NMDA-receptor encephalitis predominantly affects young people, especially women. The clinical presentation is characteristic and includes rapidly evolving behavioral changes, prominent psychiatric symptoms with delusion and psychosis, seizures, abnormal movements, autonomic instability, and central hypoventilation. Admission to the intensive care unit is common for hypoventilation or decreased consciousness. Presentation is associated with the presence of an ovarian teratoma in two-third of the cases. Diagnosis is assessed based on the identification of specific antibodies against NMDA-receptor in the CSF, as well as indirect data obtained using electroencephalography and cerebral imaging. Treatment relies on immunotherapy, corticosteroids associated to intravenous immunoglobulins or plasma exchange, and resection of the germinal tumor. If diagnosed and treated early, anti-NMDA-receptor encephalitis has a mortality rate of 4% and a favorable outcome in about two-third of the patients. Mots clésEncéphalite–NMDA–Anticorps antirécepteurs-NMDA–Encéphalite auto-immune–Encéphalite paranéoplasique KeywordsEncephalitis–NMDA–Anti-NMDA-receptor antibodies–Autoimmune encephalitis–Paraneoplastic encephalitis
    Réanimation 09/2011; 20(5):397-407. DOI:10.1007/s13546-011-0275-6
Show more